Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published November 17, 1992 | public
Journal Article

Evidence that a minor groove-binding peptide and a major groove-binding protein can simultaneously occupy a common site on DNA

Abstract

Affinity cleaving proteins have been synthesized based on the DNA-binding domain of the yeast transcriptional activator GCN4 with the DNA cleaving moiety Fe·EDTA attached at the NH_2 terminus [Oakley, M. G., & Dervan, P. B. (1990) Science 248, 847]. Cleavage patterns generated by Fe·EDTA-GCN4(226-281) bound to the DNA sites 5'-CTGACTAAT-3' and 5'-ATGACTCTT-3' reveal that the NH_2 termini of the GCN4 DNA-binding domain are located in the major groove of DNA, 9-10 base pairs apart, consistent with a Y-shaped dimeric structure. 1-Methylimidazole-2-carboxamide netropsin (2-ImN) is a designed synthetic peptide which binds in the minor groove of DNA at 5'-TGACT-3' sites as an anti parallel, side-by-side dimer [Mrksich, M., Wade, W. S., Dwyer, T. J ., Geierstanger, B. H., Wemmer, D. E., & Dervan, P. B. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 7586]. Through the use of Fe·EDTAGCN4( 226-281) as a sequence-specific footprinting agent, it is shown that the dimeric protein GCN4-(226-281) and the dimeric peptide 2-ImN can simultaneously occupy their common binding site in the major and minor grooves of DNA, respectively. The association constants for 2-ImN in the presence and in the absence of Fe·EDTA-GCN4(226-281) are found to be similar, suggesting that the binding of the two dimers is not cooperative.

Additional Information

© 1992 American Chemical Society. Received May 18, 1992; Revised Manuscript Received August 24, 1992. We thank C. S. Parker for the gift of the plasmid pARE/GCRE, S. R. Wilson (New York University) for electrospray mass spectral analysis, and S. F. Singleton and W. S. Wade for helpful discussions. This work was supported by the National Institutes of Health (GM-27681), the National Foundation for Cancer Research, a National Science Foundation predoctoral fellowship, and a National Institutes of Health predoctoral traineeship to M.G.O. and a National Institutes of Health Research Service Award to M.M.

Additional details

Created:
August 20, 2023
Modified:
October 18, 2023